NUDT17 antibody
Principal name
NUDT17 antibody
Alternative names for NUDT17 antibody
Nudix motif 17, Putative nucleoside diphosphate-linked moiety X motif 17
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of NUDT17 antibody
- Kit Component:
- - KN311323G1, Nudt17 gRNA vector 1 in pCas-Guide vector
- KN311323G2, Nudt17 gRNA vector 2 in pCas-Guide vector
- KN311323D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Gregory,S.G., (2006) Nature 441 (7091), 315-321
Human HepG2; WB Suggested Anti-NUDT17 Antibody Titration: 0.2-1 ug/ml. Positive Control: HepG2 cell lysate; NUDT17 antibody - middle region (ARP48509_P050) in Human HepG2 cells using Western Blot
WB Suggested Anti-NUDT17 Antibody Titration: 0.2-1 ug/ml; Positive Control: HepG2 cell lysate
Lysates
| Catalog No. | ||
|---|---|---|
| LY422833 | NUDT17 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216885L2V | Lenti ORF particles, Nudt17 (GFP-tagged) - Mouse nudix (nucleoside diphosphate linked moiety X)-type motif 17 (Nudt17), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR216893L2V | Lenti ORF particles, Nudt17 (GFP-tagged) - Mouse nudix (nucleoside diphosphate linked moiety X)-type motif 17 (Nudt17), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR216885L1V | Lenti ORF particles, Nudt17 (Myc-DDK-tagged) - Mouse nudix (nucleoside diphosphate linked moiety X)-type motif 17 (Nudt17), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR216893L1V | Lenti ORF particles, Nudt17 (Myc-DDK-tagged) - Mouse nudix (nucleoside diphosphate linked moiety X)-type motif 17 (Nudt17), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
